首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

1439965

睡眠呼吸中止症設備 - 全球市場回顧、競爭格局、市場預測 (2030)

Sleep Apnea Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 按訂單生產 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

全球睡眠呼吸中止設備市場規模預計到2023年將達到75.3億美元，到2030年將達到108.2億美元，2024-2030年預測期間複合年增長率為6.26%。對睡眠呼吸中止症設備的需求主要是由睡眠呼吸中止症病例數量的增加和肥胖人口的增加所推動的。此外，在 2024 年至 2030 年的預測期內，先進創新技術的採用增加、對睡眠呼吸中止症設備認識的提高、老年人口的增加以及產品發佈和批准的增加，將增加睡眠呼吸中止症設備的數量。設備市場。

睡眠呼吸中止症設備市場動態

由於多種因素，睡眠呼吸中止症設備市場的產品需求呈現正成長，其中主要因素之一是糖尿病、氣喘、鼻竇炎等盛行率的增加。

糖尿病影響呼吸的中樞控制和上呼吸道神經反射，促進睡眠障礙，並可能導致慢性阻塞性睡眠障礙，導致人們感到憂鬱和焦慮，並經歷白天焦慮。它可能導致疲勞和嗜睡，因此您可能需要睡眠設備來幫助您獲得適當的睡眠並預防憂鬱和焦慮等症狀。此外，根據IDF Diabetes Atlas第10版（2022年），2022年全球約5.37億成年人（20-79歲）將患有糖尿病，到2030年糖尿病患者總數將增至6億、4300萬人、預計到2045 年將增加到7.83 億。根據同一數據，到2022年，將有超過120萬名兒童和青少年（0-19歲）患有糖尿病。因此，糖尿病族群的增加可能會增加睡眠障礙的病例，而這些患者需要睡眠呼吸中止症來維持呼吸和上呼吸道神經反射以獲得更好的睡眠，這預計將帶動睡眠呼吸中止症的整體市場成長。

根據Sleep Foundation 2023 年 4 月的公告，睡眠不足可能導致打鼾和阻塞性睡眠障礙，對人的生活產生經濟影響。為了遏制這種經濟影響，人們需要在晚上獲得充足的睡眠，以便能夠適當地關注白天的工作。因此，人們在晚上可能需要睡眠呼吸中止症裝置。因此，失眠病例的增加將導致打鼾和阻塞性睡眠障礙的增加，最終增加預測年內對睡眠呼吸中止裝置的需求。

睡眠呼吸中止症可以在任何年齡發生，但 60 歲以上的成年人更容易患上這種疾病，因為老化與影響睡眠的心理社會因素的盛行率增加有關，因此發生的風險很高。因此，老年人口的增加將增加對睡眠呼吸中止症設備的需求。例如，根據世界衛生組織（WHO）（2022）的預測，到2030年，全球六分之一的人將超過60歲。此時，60歲及以上人口比例將從2020年的10億增加到2030年的14億。此外，到2050年，全球60歲及以上的人口將翻倍，達到近21億人。根據同一份文件的統計，2020年至2050年間，全球80歲及以上老年人的數量預計將增加兩倍，達到4.26億人。

此外，睡眠問題在老年人中更為常見，因為隨著身體年齡的增長，肌肉會減弱，氣道會塌陷，導致夜間打鼾。當舌頭、上顎和喉嚨肌肉放鬆，氣流變窄，無法正常呼吸時，就會發生打鼾。睡眠呼吸中止症治療裝置戴在您的鼻子或嘴巴上，以增加通過喉嚨的空氣量，幫助您入睡而不打鼾。因此，隨著人口老化的增加，預防打鼾和睡眠呼吸中止症的睡眠呼吸中止裝置的需求將會增加。展望未來，老年人口的增加可能會增加預測期內對睡眠呼吸中止症設備的需求。

因此，上述因素正在推動 2024-2030 年預測期內睡眠呼吸中止症設備市場的成長。

該報告提供了全球睡眠呼吸中止症設備市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

按產品類型
- 治療裝置
- 診斷裝置
按可攜性
- 便攜的
- 非便攜式
按最終用戶
- 醫院/診所
- 家庭醫療
- 其他
區域
- 北美睡眠呼吸中止設備市場規模（2021-2030）
- 歐洲睡眠呼吸中止設備市場規模（2021-2030）
- 亞太地區睡眠呼吸中止設備市場規模（2021-2030）
- 其他地區睡眠呼吸中止設備市場規模（2021-2030）

第 8 章：睡眠呼吸中止設備市場公司與產品概況

Koninklijke Philips N.V.
ResMed
Fisher & Paykel Healthcare Limited.
AMBULANC (SHENZHEN) TECH. CO. LTD
Beijing Aeonmed Co., Ltd.
BMC.
BPL Medical Technologies
Elmaslar Medikal A.S.
Hebei Topson Medical Technology Co., Ltd.
Hunan VentMed Medical Technology Co., Ltd
Vivos Therapeutics, Inc
Guangdong Pigeon Medical Apparatus Co., Ltd.
Nihon Kohden Corporation
Drive DeVilbiss International
Natus Medical Incorporated
SOMNOmedics Gmb
VYAIRE
Compumedics Limited
Nox Medical
eXciteOSA Inc.

第9章 KOL觀點

第10章項目方法

第 11 章關於 DelveInsight

第十二章免責聲明與聯絡我們

簡介目錄圖表

Product Code: DIMDCL0646

Sleep Apnea Devices Market By Product Type (Therapeutic Device [Positive Airway Pressure (PAP), Oral Appliances, Oxygen Devices, And Others] And Diagnostic Device [Pulse Oximeter, Polysomnography Devices (PSG), And Actigraphy Devices]), By Portability (Portable And Non Portable), By End-User (Hospital & Clinics, Home Healthcare, And Others), and by geography expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of sleep apnea and the rising geriatric population base across the globe

The global sleep apnea devices market was valued at USD 7.53 billion in 2023, growing at a CAGR of 6.26% during the forecast period from 2024 to 2030 to reach USD 10.82 billion by 2030. The demand for sleep apnea devices is primarily being boosted due to the increasing cases of sleep apnea, and the rising population with obesity. Further, the rising adoption of advanced and innovative technologies, the rising awareness about sleep apnea devices, the increasing geriatric population, and the increasing product launches and approval among others, thereby contribute to the overall growth of the sleep apnea devices market during the forecast period from 2024-2030.

Sleep Apnea Devices Market Dynamics:

The sleep apnea devices market is witnessing a positive growth in product demand owing to various factors, one of the key factors is the increase in the prevalence of diabetes, asthma, sinusitis, and others.

Diabetes can affect the central control of respiration and upper airway neural reflexes, promoting sleep-disordered and leading to chronic obstructive sleeping disorder which can make a person feel depressed or anxious and can lead to daytime tiredness or sleepiness, thus may need a sleeping device for proper sleep and for preventing depression or anxiety-like symptoms. Further, according to IDF Diabetes Atlas Tenth Edition 2022, in 2022 approximately 537 million adults worldwide (20-79 years) were living with diabetes, and the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. From the same source, more than 1.2 million children and adolescents (0-19 years) were living with diabetes, in 2022. Thus, the increasing population with diabetes may increase the number of sleep disturbances cases and these patients might need sleep apnea devices to maintain respiration & upper airway neural reflexes to get better sleep, thereby propelling the overall market growth of sleep apnea devices.

According to the sleep foundation April 2023, insufficient sleep may lead to snoring or obstructive sleep disorder and can create an economic impact on a person's life. To control this economic impact people need proper sleep at night so they can give proper attention to their work during the day. For this, people may need sleep apnea devices at the night. Thus, the increasing cases of insomnia will lead to an increased number of snoring or obstructive sleep disorder, ultimately increasing the demand for sleep apnea devices during the forecast year.

Sleep apnea can occur at any age, but adults older than 60 years are at a higher risk of developing this disease as aging is associated with the increasing prevalence of psychosocial factors which affect sleep. Thus, the increasing geriatric population will increase the demand for sleep apnea devices. For instance, as per World Health Organization (WHO) 2022, it is predicted that by 2030, one in six people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion in 2030, worldwide. Moreover, by 2050, the world's population of people aged 60 years and older will double which is nearly 2.1 billion. The statistics provided by the same source stated that the number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million, globally.

Further, sleep disturbance is more common in older adults because as the body ages the muscles get weakened and may lead to a collapsible airway, leading to nighttime snoring. Snoring happens when the muscles in the tongue, the roof of a person's mouth, and the throat relax which constricts airflow, and a person can't get a full breath. Sleep apnea devices are either attached to the nose or mouth to increase the amount of air that can pass through the throat and help in sleep without snoring. Thus, the increasing geriatric population will increase the need for sleep apnea devices to prevent snoring and sleep apnea. Henceforth, the increasing geriatric population may increase the demand for sleep apnea devices during the forecast period.

Therefore, the above-mentioned factors are contributing to the growth of the sleep apnea devices market during the forecast period from 2024-2030.

However, the high cost of positive airway pressure (PAP) devices, complications due to implantable devices, and others may restrict the sleep apnea devices market growth.

The sleep apnea device market was slightly significantly impacted during the period of COVID- 19 pandemic. The outbreak of the pandemic led to the cancellation of outpatient visits for treatment and surgical procedures. Further, the treatment of patients suffering from chronic diseases such as asthma, diabetes, cardiovascular disorders, sleeping disorder, and others was not a priority as compared to the covid-19 infection. Additionally, the restrictions in the supply chain, raw materials, and other resources halted the manufacture. However, the demand increased significantly with the availability of sleep apnea devices over e-commerce platforms. This led to an increase in the manufacturing of sleep apnea devices. Also, the sleep apnea device provided treatment to patients in a homecare setting, thereby avoiding frequent visits to healthcare professionals. Henceforth, the afore-said factors propelled the demand for sleep apnea devices during the pandemic and are estimated to grow similarly during the forecast period.

Sleep Apnea Devices Market Segment Analysis:

Sleep Apnea Devices Market by Product Type (Therapeutic Device [Positive Airway Pressure (PAP), Oral Appliances, Oxygen Devices, and Others], Diagnostic Device [Pulse Oximeter, Polysomnography Devices (PSG), and Actigraphy Devices]), Portability (Portable and Non-Portable), End-User (Hospital & Clinics, Home Healthcare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the sleep apnea devices market, the positive airway pressure (PAP) device category is expected to amass significant revenue share in the year 2023.

The PAP devices improve sleep quality, lower the risk of heart attack and stroke, and reduces daytime sleepiness. The device eliminates snoring and prevents sleep apnea.

The advantages of the PAP devices over other devices include less discomfort, being non-invasive, and being portable. PAP devices are likely to be the best treatment option in the management of obstructive sleep apnea.

The rising product launches and approvals will create a positive impact on the demand for PAP devices. For instance, in 2022, ResMed launched a new therapeutic air sense 11 PAP (positive airway pressure) device for sleep apnea which provides continuous air pressure to keep the upper airway open and make breathing easy. Many such developments are taking place that includes product launches and approvals, and collaborations, that can boost the segment demand in the upcoming years.

Therefore, the advantages and applications offered by PAP devices are predicted to contribute to the increasing demand for this product type thereby driving the growth of the overall sleep apnea devices market during the forecast period.

North America is expected to dominate the overall Sleep Apnea Devices Market:

Among all the regions, North America is estimated to account for the largest share of the sleep apnea devices market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of sleep apnea and insomnia, the rising geriatric population base in the region, and the rising chronic nasal congestion, are driving the North American sleep apnea devices market and are expected to witness positive growth in the forecast period. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about sleep apnea devices will also help the market growth in this region.

As per the Centers for Disease and Prevention Control (CDC) 2022, in 2020, 14.5% of adults had trouble falling asleep most days or every day in the past 30 days in the US. A greater percentage of non-Hispanic White (21.0%) adults had trouble staying asleep most days or every day compared with non-Hispanic Black (15.4%), Hispanic (10.6%), and non-Hispanic Asian (8.7%) adults. Younger adults were less likely to have trouble staying asleep (13.8% of those aged 18-44) compared with adults aged 45-64 (21.8%). Thus, people who suffer from any sleep problem due to some other disease can lead to insomnia ultimately they may also feel depression, anxiety, daytime tiredness or sleepiness, and other symptoms which may further lead to breathing disorders and snoring while sleeping. Snoring occurs when pharyngeal muscle tone is lowered during sleep, further reducing the cross-sectional area of the pharynx and leading to increased upper airway resistance. Snoring is often associated with a sleep disorder called obstructive sleep apnea (OSA). Thus, to control this condition of snoring person need a sleep apnea device people may need sleep apnea devices, ultimately increasing the demand for sleep apnea devices and thereby propelling the overall market in the North America region.

According to the CDC 2023, in 2022, 8.0% of people in the US aged 18 and over had asthma. As per the same source, the annual number of hospital visits for asthma was 4.9 million, in 2022, in the US. Asthma causes inflammation and narrowing of the airways, which can trigger irritation and constriction of the small airways which can lead to sleep deprivation. Thus, to maintain these cases of sleep deprivation due to asthma sleep apnea devices can be used. These devices involve wearing a nasal or face mask attached to a machine that delivers continuous air pressure to keep the upper airway open and make breathing easy. Thus, by wearing this device asthma patients can take proper sleep and prevent themselves from sleep deprivation. Hence, increasing cases of asthma will lead to an increase in the demand for sleep apnea devices.

Thus, the aforementioned factors will increase the demand for sleep apnea devices, thereby driving the North American sleep apnea devices market forward during the forecast period.

Sleep Apnea Devices Market Key Players:

Some of the key market players operating in the sleep apnea devices market include Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare Limited, and AMBULANCE (SHENZHEN) TECH. CO. LTD, BMC, Beijing Aeonmed Co., Ltd., Hebei Topson Medical Technology Co., Ltd., Hunan VentMed Medical Technology Co., Ltd, Vivos Therapeutics, Inc, Guangdong Pigeon Medical Apparatus Co., Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, SOMNOmedics Gmb, VYAIRE, Compumedics Limited, Drive DeVilbiss International, Nox Medical, eXciteOSA Inc., and others.

Recent Developmental Activities in the Sleep Apnea Devices Market:

In October 2022, Airway Management, announced the launch of flexTAP, a premium lab-made oral appliance, which is designed to treat patients with snoring and mild to moderate obstructive sleep apnea.

In August 2022, Vivos Therapeutics, Inc, received FDA approval for intraoral devices used for snoring and obstructive sleep apnea.

In March 2020, the FDA approved, eXciteOSA by signifier medical technologies, a neuromuscular tongue muscle stimulator for the reduction of snoring and obstructive sleep apnea.

Key Takeaways from the Sleep Apnea Devices Market Report Study

Market size analysis for current sleep apnea devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the sleep apnea devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global sleep apnea devices market.

Various opportunities are available for the other competitor in the sleep apnea devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current sleep apnea devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for sleep apnea devices market growth in the coming future?

Target Audience who can be benefited from this Sleep Apnea Devices Market Report Study

Sleep apnea devices products providers

Research organizations and consulting companies

Sleep apnea devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in sleep apnea devices

Various End-users who want to know more about the sleep apnea devices market and the latest technological developments in the sleep apnea devices market

Frequently Asked Questions for the Sleep Apnea Devices Market:

1. What is a sleep apnea device?

Sleep apnea device is one of the most common therapies for obstructive sleep apnea. It keeps airways open while sleeping so a person can receive oxygen properly. Sleep apnea devices can significantly improve sleep quality and reduce the risk of several health issues.

2. What is the market for global sleep apnea devices?

The global sleep apnea devices market was valued at USD 7.53 billion in 2023, growing at a CAGR of 6.26% during the forecast period from 2024 to 2030 to reach USD 10.82 billion by 2030.

3. What are the drivers for the global sleep apnea devices market?

The demand for sleep apnea devices is primarily being heightened by the increasing prevalence of obstructive sleep apnea disorders and the increasing chronic diseases which lead to sleep disturbance. In addition, the advancement in sleep apnea devices, the increasing device launches, and approvals among others are thereby contributing to the overall growth of the sleep apnea devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global sleep apnea devices market?

5. Which region has the highest share in the sleep apnea devices market?

North America is expected to dominate the overall sleep apnea devices market during the forecast period from 2024-2030. Factors such as the rising geriatric population, the rising cases of obesity, the increasing cases of insomnia, and others will propel the demand for sleep apnea devices in North America. Furthermore, increasing technological advancement, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about sleep apnea diseases also helped the market growth in this region.

1. Sleep Apnea Devices Market Report Introduction

2. Sleep Apnea Devices Market Executive Summary

2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. Sleep Apnea Devices Market Key Factors Analysis

4.1. Sleep Apnea Devices Market Drivers
- 4.1.1. Increasing prevalence of obstructive sleep apnea (OSA)
- 4.1.2. Rising geriatric population, rising number of obesity, hypertension, and other risk factors across the globe
- 4.1.3. Increasing awareness among people about sleep apnea devices such as nose clips, chin straps, and others
4.2. Sleep Apnea Devices Market Restraints and Challenges
- 4.2.1. Complications related to implantable sleep apnea devices
- 4.2.2. High cost of Positive Airway Pressure (PAP) devices
4.3. Sleep Apnea Devices Market Opportunities
- 4.3.1. Technological advancements in sleep apnea device

5. Sleep Apnea Devices Market Porter's Five Forces Analysis

5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. The threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Sleep Apnea Devices Market

7. Sleep Apnea Devices Market Layout

7.1. By Product Type
- 7.1.1. Therapeutic Device
  - 7.1.1.1. Positive Airway Pressure (PAP)
  - 7.1.1.2. Oral Appliances
  - 7.1.1.3. Oxygen devices
  - 7.1.1.4. Others
- 7.1.2. Diagnostic Device
  - 7.1.2.1. Pulse Oximeter
  - 7.1.2.2. Polysomnography Devices (PSG)
  - 7.1.2.3. Actigraphy Devices
7.2. By Portability
- 7.2.1. Portable
- 7.2.2. Non Portable
7.3. By End-User
- 7.3.1. Hospital & Clinics
- 7.3.2. Home healthcare
- 7.3.3. Others
7.4. By Geography
- 7.4.1. North America Sleep Apnea Devices Market Size in USD Million (2021-2030)
  - 7.4.1.1. The United States Sleep Apnea Devices Market Size in USD Million (2021-2030)
  - 7.4.1.2. Canada Sleep Apnea Devices Market Size in USD Million (2021-2030)
  - 7.4.1.3. Mexico Sleep Apnea Devices Market Size in USD Million (2021-2030)
- 7.4.2. Europe Sleep Apnea Devices Market Size in USD Million (2021-2030)
  - 7.4.2.1. France Sleep Apnea Devices Market Size in USD Million (2021-2030)
  - 7.4.2.2. Germany Sleep Apnea Devices Market Size in USD Million (2021-2030)
  - 7.4.2.3. United Kingdom Sleep Apnea Devices Market Size in USD Million (2021-2030)
  - 7.4.2.4. Italy Sleep Apnea Devices Market Size in USD Million (2021-2030)
  - 7.4.2.5. Spain Sleep Apnea Devices Market Size in USD Million (2021-2030)
  - 7.4.2.6. Rest of Europe Sleep Apnea Devices Market Size in USD Million (2021-2030)
- 7.4.3. Asia-Pacific Sleep Apnea Devices Market Size in USD Million (2021-2030)
  - 7.4.3.1. China Sleep Apnea Devices Market Size in USD Million (2021-2030)
  - 7.4.3.2. Japan Sleep Apnea Devices Market Size in USD Million (2021-2030)
  - 7.4.3.3. India Sleep Apnea Devices Market Size in USD Million (2021-2030)
  - 7.4.3.4. Australia Sleep Apnea Devices Market Size in USD Million (2021-2030)
  - 7.4.3.5. South Korea Sleep Apnea Devices Market Size in USD Million (2021-2030)
  - 7.4.3.6. Rest of Asia-Pacific Sleep Apnea Devices Market Size in USD Million (2021-2030)
- 7.4.4. Rest of the World (RoW) Sleep Apnea Devices Market Size in USD million (2021-2030)
  - 7.4.4.1. Middle East Sleep Apnea Devices Market Size in USD Million (2021-2030)
  - 7.4.4.2. Africa Sleep Apnea Devices Market Size in USD Million (2021-2030)
  - 7.4.4.3. South America Sleep Apnea Devices Market Size in USD Million (2021-2030)

8. Sleep Apnea Devices Market Company and Product Profiles

8.1. Koninklijke Philips N.V.
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. ResMed
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. Fisher & Paykel Healthcare Limited.
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. AMBULANC (SHENZHEN) TECH. CO. LTD
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. Beijing Aeonmed Co., Ltd.
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. BMC.
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. BPL Medical Technologies
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. Elmaslar Medikal A.S.
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. Hebei Topson Medical Technology Co., Ltd.
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy
8.10. Hunan VentMed Medical Technology Co., Ltd
- 8.10.1. Company Overview
- 8.10.2. Company Snapshot
- 8.10.3. Financial Overview
- 8.10.4. Product Listing
- 8.10.5. Entropy
8.11. Vivos Therapeutics, Inc
- 8.11.1. Company Overview
- 8.11.2. Company Snapshot
- 8.11.3. Financial Overview
- 8.11.4. Product Listing
- 8.11.5. Entropy
8.12. Guangdong Pigeon Medical Apparatus Co., Ltd.
- 8.12.1. Company Overview
- 8.12.2. Company Snapshot
- 8.12.3. Financial Overview
- 8.12.4. Product Listing
- 8.12.5. Entropy
8.13. Nihon Kohden Corporation
- 8.13.1. Company Overview
- 8.13.2. Company Snapshot
- 8.13.3. Financial Overview
- 8.13.4. Product Listing
- 8.13.5. Entropy
8.14. Drive DeVilbiss International
- 8.14.1. Company Overview
- 8.14.2. Company Snapshot
- 8.14.3. Financial Overview
- 8.14.4. Product Listing
- 8.14.5. Entropy
8.15. Natus Medical Incorporated
- 8.15.1. Company Overview
- 8.15.2. Company Snapshot
- 8.15.3. Financial Overview
- 8.15.4. Product Listing
- 8.15.5. Entropy
8.16. SOMNOmedics Gmb
- 8.16.1. Company Overview
- 8.16.2. Company Snapshot
- 8.16.3. Financial Overview
- 8.16.4. Product Listing
- 8.16.5. Entropy
8.17. VYAIRE
- 8.17.1. Company Overview
- 8.17.2. Company Snapshot
- 8.17.3. Financial Overview
- 8.17.4. Product Listing
- 8.17.5. Entropy
8.18. Compumedics Limited
- 8.18.1. Company Overview
- 8.18.2. Company Snapshot
- 8.18.3. Financial Overview
- 8.18.4. Product Listing
- 8.18.5. Entropy
8.19. Nox Medical
- 8.19.1. Company Overview
- 8.19.2. Company Snapshot
- 8.19.3. Financial Overview
- 8.19.4. Product Listing
- 8.19.5. Entropy
8.20. eXciteOSA Inc.
- 8.20.1. Company Overview
- 8.20.2. Company Snapshot
- 8.20.3. Financial Overview
- 8.20.4. Product Listing
- 8.20.5. Entropy